A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that loss of sight could be a side effect.

A local Bentonville family shares their story with Type One Diabetes and discusses the latest therapies and funded research.

A few hundred union members and supporters rallied at Spellerberg Park in Sioux Falls to raise concerns about how they believe losing employees might impact veterans’ healthcare.

NOLENSVILLE, Tenn. (WSMV) - A woman missing from another state was located in Tennessee within minutes of her car being read ...

Apple cider vinegar (ACV) offers many benefits, from enhancing weight loss to improving blood sugar levels. Learn whether ACV ...

A team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms. This technique is indistinguishable from natural variation and enabled the researchers to ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

Like many government institutions, the National Institutes of Health (NIH) faces big budget cuts and a dramatic restructuring ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

In 2024, the U.S. healthcare industry spent $6.1 billion on Pfizer’s COVID-19 therapy Paxlovid, a 6,922.8% increase from 2023 expenditure data, according to a recent study. The research, published ...

Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a ...

A new study looked into risk factors for having a stroke earlier in life and found a surprising link to a fairly common issue ...